These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18330892)

  • 1. Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema.
    Doukas J; Mahesh S; Umeda N; Kachi S; Akiyama H; Yokoi K; Cao J; Chen Z; Dellamary L; Tam B; Racanelli-Layton A; Hood J; Martin M; Noronha G; Soll R; Campochiaro PA
    J Cell Physiol; 2008 Jul; 216(1):29-37. PubMed ID: 18330892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of prodrug 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl benzoate (TG100801): a topically administered therapeutic candidate in clinical trials for the treatment of age-related macular degeneration.
    Palanki MS; Akiyama H; Campochiaro P; Cao J; Chow CP; Dellamary L; Doukas J; Fine R; Gritzen C; Hood JD; Hu S; Kachi S; Kang X; Klebansky B; Kousba A; Lohse D; Mak CC; Martin M; McPherson A; Pathak VP; Renick J; Soll R; Umeda N; Yee S; Yokoi K; Zeng B; Zhu H; Noronha G
    J Med Chem; 2008 Mar; 51(6):1546-59. PubMed ID: 18311895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting intraocular neovascularization and edema--one drop at a time.
    Aiello LP
    N Engl J Med; 2008 Aug; 359(9):967-9. PubMed ID: 18753655
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
    Seo S; Suh W
    Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-angiogenic effects of the receptor tyrosine kinase inhibitor, pazopanib, on choroidal neovascularization in rats.
    Yafai Y; Yang XM; Niemeyer M; Nishiwaki A; Lange J; Wiedemann P; King AG; Yasukawa T; Eichler W
    Eur J Pharmacol; 2011 Sep; 666(1-3):12-8. PubMed ID: 21620822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An anti-inflammatory role of VEGFR2/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology.
    Sharma S; Mulik S; Kumar N; Suryawanshi A; Rouse BT
    J Virol; 2011 Jun; 85(12):5995-6007. PubMed ID: 21471229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HIF-1 antagonist acriflavine: visualization in retina and suppression of ocular neovascularization.
    Zeng M; Shen J; Liu Y; Lu LY; Ding K; Fortmann SD; Khan M; Wang J; Hackett SF; Semenza GL; Campochiaro PA
    J Mol Med (Berl); 2017 Apr; 95(4):417-429. PubMed ID: 28004126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing a novel depot delivery strategy for noninvasive administration of VEGF/PDGF RTK inhibitors for ocular neovascular disease.
    Robbie SJ; Lundh von Leithner P; Ju M; Lange CA; King AG; Adamson P; Lee D; Sychterz C; Coffey P; Ng YS; Bainbridge JW; Shima DT
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1490-500. PubMed ID: 23385800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine kinase blocking collagen IV-derived peptide suppresses ocular neovascularization and vascular leakage.
    Silva RLE; Kanan Y; Mirando AC; Kim J; Shmueli RB; Lorenc VE; Fortmann SD; Sciamanna J; Pandey NB; Green JJ; Popel AS; Campochiaro PA
    Sci Transl Med; 2017 Jan; 9(373):. PubMed ID: 28100839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brivanib, a multitargeted small-molecule tyrosine kinase inhibitor, suppresses laser-induced CNV in a mouse model of neovascular AMD.
    Li L; Zhu M; Wu W; Qin B; Gu J; Tu Y; Chen J; Liu D; Shi Y; Liu X; Sang A; Ding D
    J Cell Physiol; 2020 Feb; 235(2):1259-1273. PubMed ID: 31270802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Experimental Choroidal Neovascularization by a Novel Peptide Derived from Calreticulin Anti-Angiogenic Domain.
    Bee YS; Ma YL; Chen J; Tsai PJ; Sheu SJ; Lin HC; Huang H; Liu GS; Tai MH
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical nepafenac inhibits ocular neovascularization.
    Takahashi K; Saishin Y; Saishin Y; Mori K; Ando A; Yamamoto S; Oshima Y; Nambu H; Melia MB; Bingaman DP; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):409-15. PubMed ID: 12506103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal Inhibition of CCR3 Induces Retinal Cell Death in a Murine Model of Choroidal Neovascularization.
    Wang H; Han X; Gambhir D; Becker S; Kunz E; Liu AJ; Hartnett ME
    PLoS One; 2016; 11(6):e0157748. PubMed ID: 27309355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
    Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X
    Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic effects of topically administered multiple kinase inhibitor, motesanib (AMG 706), on experimental choroidal neovascularization in mice.
    Rho CR; Kang S; Park KC; Yang KJ; Choi H; Cho WK
    J Ocul Pharmacol Ther; 2015 Feb; 31(1):25-31. PubMed ID: 25255037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axitinib inhibits retinal and choroidal neovascularization in in vitro and in vivo models.
    Giddabasappa A; Lalwani K; Norberg R; Gukasyan HJ; Paterson D; Schachar RA; Rittenhouse K; Klamerus K; Mosyak L; Eswaraka J
    Exp Eye Res; 2016 Apr; 145():373-379. PubMed ID: 26927930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice.
    Dejneka NS; Kuroki AM; Fosnot J; Tang W; Tolentino MJ; Bennett J
    Mol Vis; 2004 Dec; 10():964-72. PubMed ID: 15623986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization.
    Caballero S; Swaney J; Moreno K; Afzal A; Kielczewski J; Stoller G; Cavalli A; Garland W; Hansen G; Sabbadini R; Grant MB
    Exp Eye Res; 2009 Mar; 88(3):367-77. PubMed ID: 18723015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic effects of tivozanib, an oral VEGF receptor tyrosine kinase inhibitor, on experimental choroidal neovascularization in mice.
    Kang S; Roh YJ; Kim IB
    Exp Eye Res; 2013 Jul; 112():125-33. PubMed ID: 23701975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.